M2Gen Board of Directors

M2Gen® is a health informatics solutions company focused on accelerating the discovery and development of personalized medicines. M2Gen partners with the nation’s leading cancer centers through ORIEN to create a large, cancer-focused data warehouse linking clinical and molecular data. Using this information, M2Gen helps biopharmaceutical companies address the greatest challenges in oncology drug development.

Dr. William Dalton
William S. Dalton, Ph.D., M.D., Executive Chair
Past Directo, Personalized Medicine Institute,
Moffitt Cancer Center

James Asher
Mr. James M. Asher
Senior Vice President, Chief Legal &  Development Officer
Hearst Health

Ted Couch
Mr. Theodore J. Couch, Sr.
President
Premium Mortgage, Inc.

Greg Dorn
Gregory Dorn, M.D., MPH
President
Hearst Health

Alan List
Alan F. List, M.D.
President & CEO
Moffitt Cancer Center


Senator Connie Mack
Founding Partner & Senior Policy Advisor
Liberty Partners Group, LLC

Richard Malloch
Mr. Richard P. Malloch
President
Hearst Business Media

Allan Martin
Mr. Allan S. Martin
Co-Founder & CEO
Lumina Analytics

Raphael Pollock
Raphael E. Pollock, MD, PhD, FACS (Non-voting, OSU Observer Designee)


Mr. Robert Rothman
President & CEO
Black Diamond Group

Thomas Sellers
Thomas Sellers, Ph.D., MPH
Center Director
Moffitt Cancer Center

Steve Swartz
Mr. Steven R. Swartz (Non-voting, OSU Observer Designee)
President & CEO
Hearst Health

Tim Wright
Mr. Timothy R. Wright
President/CEO
M2Gen